Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 3.94 -0.11 (2.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $18.00 | |||
| Open | $4.04 | 52 Week Low | $6.91 | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $-0.67 | |||
| Volume | 246,815 | |||||
